M S Co
M S Co publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry, on topics such as Monoclonal and Polyclonal Antibodies Research, Protein purification and stability and Glycosylation and Glycoproteins Research.
- World rank
- #1,453,016 of 7,710,434 ranked researchers
- Rank in United States
- #457,103 of 1,627,098
- Works
- 22
- Citations
- 1.3k
- Citations per work
- 57.0
What does M S Co research?
M S Co's work is mostly in Biochemistry, Genetics and Molecular Biology (24%), Medicine (19%), Chemistry (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1045.1%
- Life Sciences524.2%
- Health Sciences419.4%
- Medicine419.4%
- Physical Sciences211.3%
- Chemistry211.3%
- 1Molecular Biology19% of their works
- 2Radiology, Nuclear Medicine and Imaging13% of their works
- 3Organic Chemistry6% of their works
- 4Infectious Diseases6% of their works
- 5Genetics5% of their works
- 6Inorganic Chemistry5% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Protein purification and stability
- Glycosylation and Glycoproteins Research
- Viral gastroenteritis research and epidemiology
- Transgenic Plants and Applications
- Virus-based gene therapy research
- Metal-Catalyzed Oxygenation Mechanisms
- Inorganic and Organometallic Chemistry
Which keywords describe M S Co's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Antibody Engineering, Fc Receptors, Biopharmaceuticals, Recombinant Proteins and Protein Aggregation.
- Vaccine Antigens
- Organic Synthesis
- Gene Therapy
- Catalysis
- Norovirus
- Cancer
- Protein Aggregation
- Biopharmaceuticals
- Antibody Engineering
- Therapeutic Antibodies
- Monoclonal Antibodies
- Glycosylation
- Fc Receptors
- Recombinant Proteins
- Stability
- Glycans
- Rotavirus
- Dioxygen Activation
- Metalloenzyme
- Plant Molecular Farming
- Viral Vectors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Monoclonal Antibodies122 topics
- Therapeutic Antibodies122 topics
- Glycosylation112 topics
- Antibody Engineering81 topic
- Fc Receptors81 topic
- Biopharmaceuticals62 topics
- Recombinant Proteins62 topics
- Protein Aggregation41 topic
- Stability41 topic
- Cancer31 topic
- Glycans31 topic
- Norovirus31 topic
- Rotavirus31 topic
- Catalysis21 topic
- Dioxygen Activation21 topic
- Gene Therapy21 topic
- Metalloenzyme21 topic
- Organic Synthesis21 topic
- Plant Molecular Farming21 topic
- Vaccine Antigens21 topic
- Viral Vectors21 topic
Where does M S Co work?
M S Co's main affiliation in the publication record is PDL BioPharma (United States), United States.
How many publications and citations does M S Co have?
OpenAlex counts 22 works and 1,253 citations for M S Co, an h-index of 15, ranking #1,453,016 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about M S Co. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.